Evolving Immunogenicity Bioanalysis for Vaccines and Biotherapeutics
- Published August 20, 2026
- Speakers 1
- Registration required
Complete the form to watch
Watch the on-demand webinar
Complete the short form below and the recording will start straight away.
Loading the form…
Our form service could not be reached. Please use the form below instead.
About this webinar
Immunogenicity assessment remains a critical component in the development of vaccines and biotherapeutics, with distinct analytical strategies and regulatory expectations across modalities.
This on-demand webinar explores the evolving landscape of immunogenicity bioanalysis, highlighting the key differences between vaccine and biologics workflows, and the growing importance of robust ADA (anti-drug antibody) strategies.